- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00729781
Study of Polyester Implants for the Treatment of External Nasal Valve Collapse (NVC) (NVC)
Open Label, Baseline Controlled Study to Evaluate the Use of Polyethylene Terephthalate (PET) Implants for the Treatment of External Nasal Valve Collapse and Cosmetic Contour Deformity
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The effects of PET implants on external NVC and cosmetic contour deformity will be evaluated in an open-label, prospective study. Subjects for this clinical study will be recruited and screened from clinic office visits and patient records at each principal investigator's site as well as through an investigational review board (IRB)-approved general advertisement. Those patients that continue to qualify after either screening process will be seen and evaluated by one of the clinical investigators prior to enrollment in the study. Subjects must meet criteria for the diagnosis of external nasal valve collapse as a stand alone abnormality (i.e., symptoms of obstruction cannot be caused primarily by other factors). Other contributing factors to the nasal obstruction must be ruled out and/or treated, without relief before enrollment in this study. No other surgeries or procedures will be allowed during the study that could influence the evaluation of implants on the treatment of nasal valve collapse and cosmetic contour deformity. All subjects will be required to sign an IRB approved informed consent prior to entry into the study.
After meeting inclusion/exclusion criteria and completing the pre-implant evaluations, subjects will be scheduled for treatment with the polyethylene terephthalate implants. The implant procedure will be performed by facial plastic physicians. All investigative sites will be required to undergo training to standardize the methodology of implant technique and administration of evaluation techniques (questionnaires, scales, photographic assessments, etc.). Target sample size for the study will be 72 subjects.
Follow up evaluations for all outcome measures will occur at 1, 6, and 12 weeks after implantation. Long-term follow-up for adverse events will be conducted at 11 months or later after implantation.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
California
-
Sacramento, California, United States, 95817-2207
- UC Davis Medical Center
-
-
Georgia
-
Atlanta, Georgia, United States, 30338-6408
- Premier Image Cosmetic & Laser
-
-
Illinois
-
Downers Grove, Illinois, United States, 60515
- DuPage Medical Group, Ltd
-
-
Michigan
-
Sterling Heights, Michigan, United States, 48314
- Ear, Nose, & Throat Physicians
-
-
Minnesota
-
St. Paul, Minnesota, United States, 55130
- HealthPartners Specialty Clinic/Regions Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Is willing and able to sign an informed consent form
- Is 18 years of age or older
Has positive response to any of the following based on patient history or office exam:
- Use of Breath Rite Strips
- Q-Tip test
- Use of Nasal stents
- Continuous manual distraction
- Has inspiratory lateral nasal wall collapse or static medially obstructing lateral nasal wall position identified on physical exam
- Has nasal valve that is narrow (either static or dynamic) based on a visual examination.
- Has nasal septum that is considered stable and adequate to support the treatment of each nasal valve independently.
- Is motivated and willing to comply with study and its follow-up requirements, including surgical intervention using the Pillar implant system for the treatment of nasal valve collapse
- Speaks English
- Has unilateral or bilateral nasal valve collapse
Exclusion Criteria:
- Has ability to achieve active nostril dilation and relieve obstruction using physiologic nasal alar and sidewall muscle actions
- Has chronic sinusitis, recurrent sinusitis, or allergies leading to nasal obstruction.
- Has active nasal infection
- Has skin inflammation in the nasal area
- Is a habitual chronic sniffer
- Has septal deviation, turbinate hypertrophy, polyps, or ptotic nose tip believed to be causing obstruction
- Has had previous rhinoplasty of external nasal frame
- Requires another surgery other than implants to correct an obstruction
- Has nasal anatomy that is inadequate to accommodate three 18 mm implants
- Is participating in a clinical study for another treatment for nasal valve collapse
- Is pregnant or desires to become pregnant during the duration of the study
- Has a history of drug abuse or alcoholism in the year before enrollment
- Has had previous surgery for external nasal valve collapse
- Has an American Society of Anesthesiologists (ASA) rating of III or IV
- Has any other condition believed to interfere with nasal assessments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Polyester Implants
There is one arm for this study.
All subjects in this study will receive the investigational nasal implants.
See the detailed description for procedure information.
|
Three polyester (PET) implants will be implanted in each side of the nose affected by external NVC.
See the detailed description for information about the implant procedure.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional Improvement
Time Frame: 12 weeks after implantation
|
Functional improvement was defined as a subject who achieves both 1) an improvement in the physical condition of the collapsed nasal valve as evidenced by an increase of >= 10% in the change in volume during inspiration as measured by Vectra 3D photography from baseline to 12 weeks post-procedure; and 2) a reduction of at least 30% in the symptoms of nasal obstruction as measured by the Nasal Obstruction Symptom Evaluation Scale (NOSE) scale (5 questions with 0-4 scale from "Not a problem" to "Severe problem," possible score 0-100 via raw score × 5) from baseline to 12 weeks post-procedure.
|
12 weeks after implantation
|
Cosmetic Improvement
Time Frame: 12 weeks after implantation
|
An independent clinician will review Vectra 3D photographs of each subject at baseline and at 12 weeks post-procedure to assess physical appearance of the external nasal wall.
The clinician will be asked to determine which photographs are pre-treatment and which are post-treatment in the correct order.
The clinician will then rate the photograph chosen as post-treatment using the Global Aesthetic Improvement Scale (GAIS; relative scale from "Worse" to "Very much improved").
If the post-treatment photograph was not correctly identified, that procedure will receive a "worse" on the rating scale.
|
12 weeks after implantation
|
Safety
Time Frame: During 12-week original study and at long-term follow-up of 11 months or longer
|
Evaluate complications and adverse events.
Events are presented descriptively with no statistical analysis.
|
During 12-week original study and at long-term follow-up of 11 months or longer
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Terry L Donat, MD, Institute of Aesthetic Surgery
Publications and helpful links
General Publications
- Hurbis CG. An adjustable, butterfly-design, titanium-expanded polytetrafluoroethylene implant for nasal valve dysfunction: a pilot study. Arch Facial Plast Surg. 2006 Mar-Apr;8(2):98-104. doi: 10.1001/archfaci.8.2.98.
- Stewart MG, Witsell DL, Smith TL, Weaver EM, Yueh B, Hannley MT. Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Otolaryngol Head Neck Surg. 2004 Feb;130(2):157-63. doi: 10.1016/j.otohns.2003.09.016.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 925
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nasal Alar Collapse, Bilateral
-
Philips Clinical & Medical Affairs GlobalNot yet recruitingOxygen | SpO2 | Nasal Alar Collapse, Bilateral | Measurement
-
Baskent University Ankara HospitalCompletedNasal Valve Incompetence | Alar CollapseTurkey
-
Spirox, Inc.CompletedNasal Valve CollapseGermany
-
Spirox, Inc.New Arch ConsultingCompletedNasal Breathing | Nasal Valve CollapseUnited States
-
University of VirginiaPortland VA Medical CenterWithdrawnNasal Valve Incompetence
-
Optinose US Inc.CompletedBilateral Nasal PolyposisUnited States
-
Yuzuncu Yıl UniversityCompleted
-
Optinose US Inc.RecruitingBilateral Nasal PolyposisUnited States
-
HNO-Praxis Alte PostAerin MedicalCompletedNasal Obstruction, BilateralGermany
Clinical Trials on Polyester Implants
-
Muğla Sıtkı Koçman UniversityRecruitingUrinary Incontinence | Pelvic Floor DisordersTurkey
-
Yuzuncu Yıl UniversityCompletedImpacted Third Molar ToothTurkey
-
Fundacion Clinica Valle del LiliCompleted
-
Ain Shams UniversityCompletedCompletely Edentulous PatientsEgypt
-
Shanghai Ninth People's Hospital Affiliated to...Completed
-
National Research Centre, EgyptCompleted
-
Nourhan M.AlyAlexandria UniversityCompletedMandibular Bone ResorptionEgypt
-
Pooriwat LertsurawatKittipon NaratrikunActive, not recruiting
-
Motiva USA LLCActive, not recruitingBreast ImplantsUnited States, Germany, Sweden
-
University of LiegeMIS Implant Technologies, LtdCompleted